Selected technologies to control genes and their products for experimental and clinical purposes

被引:21
作者
Alexander, Helen K.
Booy, Evan P.
Xiao, Wenyan
Ezzati, Peyman
Baust, Heinrich
Los, Marek
机构
[1] Univ Manitoba, Manitoba Inst Cell Biol, Canc Care Manitoba, Winnipeg, MB R3E 0V9, Canada
[2] Univ Manitoba, Dept Human Anat & Cell Sci, Winnipeg, MB R3E 0V9, Canada
[3] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB R3E 0V9, Canada
[4] Univ Erlangen Nurnberg, Dept Radiooncol, D-8520 Erlangen, Germany
基金
加拿大健康研究院;
关键词
Dicer; Drosha; FKBP; gene silencing; Mifepristone; mutagensis; N-degron; NF-kappa B; RISC;
D O I
10.1007/s00005-007-0025-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
On-demand regulation of gene expression is a powerful tool to elucidate the functions of proteins and biologically-active RNAs. We describe here three different approaches to the regulation of expression or activity of genes or proteins. Promoter-based regulation of gene expression was among the most rapidly developing techniques in the 1980s and 1990s. Here we provide basic information and also some characteristics of the metallothionein-promoter-based system, the tet-off system, Muristerone-A-regulated expression through the ecdysone response element, RheoSwitch (R), coumermycin/novobiocin-regulated gene expression, chemical dimerizer-based promoter activation systems, the "Dual Drug Control" system, "constitutive androstane receptor"-based regulation of gene expression, and RU486/mifepristone-driven regulation of promoter activity. A large part of the review concentrates on the principles and usage of various RNA interference techniques (RNAi: siRNA, shRNA, and miRNA-based methods). Finally, the last part of the review deals with historically the oldest, but still widely used, methods of temperature-dependent regulation of enzymatic activity or protein stability (temperature-sensitive mutants). Due to space limitations we do not describe in detail but just mention the tet-regulated systems and also fusion-protein-based regulation of protein activity, such as estrogen-receptor fusion proteins. The information provided below is aimed to assist researchers in choosing the most appropriate method for the planned development of experimental systems with regulated expression or activity of studied proteins.
引用
收藏
页码:139 / 149
页数:11
相关论文
共 85 条
[1]   Regulation of radiation-induced apoptosis by early growth response-1 gene in solid tumors [J].
Ahmed, MM .
CURRENT CANCER DRUG TARGETS, 2004, 4 (01) :43-52
[2]   A versatile synthetic dimerizer for the regulation of protein-protein interactions [J].
Amara, JF ;
Clackson, T ;
Rivera, VM ;
Guo, T ;
Keenan, T ;
Natesan, S ;
Pollock, R ;
Yang, W ;
Courage, NL ;
Holt, DA ;
Gilman, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (20) :10618-10623
[3]   Methods and biomarkers for the diagnosis and prognosis of cancer and other diseases: Towards personalized medicine [J].
Anderson, Judy E. ;
Hansen, Lise Lotte ;
Mooren, Frank C. ;
Post, Markus ;
Hug, Hubert ;
Zuse, Anne ;
Los, Marek .
DRUG RESISTANCE UPDATES, 2006, 9 (4-5) :198-210
[4]   Important differences between topoisomerase-I and -II targeting agents [J].
Banerji, Shantanu ;
Los, Marek .
CANCER BIOLOGY & THERAPY, 2006, 5 (08) :965-966
[5]   Serum cytochrome c indicates in vivo apoptosis and can serve as a prognostic marker during cancer therapy [J].
Barczyk, K ;
Kreuter, M ;
Pryjma, J ;
Booy, EP ;
Maddika, S ;
Ghavami, S ;
Berdel, WE ;
Roth, J ;
Los, M .
INTERNATIONAL JOURNAL OF CANCER, 2005, 116 (02) :167-173
[6]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[7]   Gene regulation by tetracyclines - Constraints of resistance regulation in bacteria shape TetR for application in eukaryotes [J].
Berens, C ;
Hillen, W .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2003, 270 (15) :3109-3121
[8]   A large-scale RNAi screen in human cells identifies new components of the p53 pathway [J].
Berns, K ;
Hijmans, EM ;
Mullenders, J ;
Brummelkamp, TR ;
Velds, A ;
Heimerikx, M ;
Kerkhoven, RM ;
Madiredjo, M ;
Nijkamp, W ;
Weigelt, B ;
Agami, R ;
Ge, W ;
Cavet, G ;
Linsley, PS ;
Beijersbergen, RL ;
Bernards, R .
NATURE, 2004, 428 (6981) :431-437
[9]  
Blagosklonny Mikhail V., 2005, P357, DOI 10.1007/0-387-23695-3_17
[10]   Monoclonal and bispecific antibodies as novel therapeutics [J].
Booy, EP ;
Johar, D ;
Maddika, S ;
Pirzada, H ;
Sahib, MM ;
Gehrke, I ;
Loewen, S ;
Louis, SF ;
Kadkhoda, K ;
Mowat, M ;
Los, M .
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2006, 54 (02) :85-101